Clinical Evaluation of Anti-inflammatory and Analgesic Activities of AQUA-TURM (branded extract of Curcuma longa) in Individuals Suffering from Osteoarthritis of Knee(s): A Randomized, Double Blind, Placebo Controlled clinical study

Author:

Pande Shishir1,Godatwar Pawankumar2,Agiwal Sachin3,Khatau Kiran4,Tamoli Sanjay5

Affiliation:

1. Ayurved Seva Sanghs, Ayurved Mahavidyalaya, OPD No 7A, Ground Floor, Ayurved, Sanshodhan Vibhag, Ayurved Seva Sanghs, Ayurved Mahavidyalaya, Ganeshwadi, Panchvati, Nashik –422003

2. National Institute of Ayurveda, Jorawar Sing Gate, Amer Road, Jaipur, Rajasthan 302002

3. Shri. Gurudeo Ayurved College, Gurukunj Ashram, Tal. Tiosa, Dist. Amravati, Pin Code - 444902

4. Lodaat Pharma, 1415 West 22nd Street-Tower Floor, Oak Brook, Illinois 60523, USA

5. Target Institute of Medical Education & Research, 402/A, A, B, C, Jaswanti Allied Business Centre, Off Link Road, Malad West, Mumbai, India 400064

Abstract

Abstract Background: Anti-inflammatory and analgesic activities of Curcuma longa extract can be helpful in the management of Osteoarthritis. Objectives: to evaluate the anti-inflammatory and analgesic activities of AQUATURM® (branded extract of Curcuma longa) in individuals suffering from Osteoarthritis of Knee joint Methods: In present randomized, double blind, placebo controlled clinical study, a total 60 participants suffering from Osteoarthritis of the knee joint were randomized in two groups through a double-blinded procedure. AQUA-TURM® or its matching placebo was given in a dose of 1 capsule of 250 mg twice daily after meals for 90 days. Of these, 56 subjects completed the study (26 in AQUA-TURM® group and 30 in placebo group). Assessment of comparative change in knee joint pain on VAS, WOMAC Index was done on monthly intervals. Other parameters like time to walk 50 feet, requirement of painkillers, changes in the CRP levels and safety assessment through adverse event monitoring and laboratory parameters was done. Results: A significant reduction (p < 0.05) in pain was observed on VAS scale with the use of AQUA-TURM® as compared to placebo over a period of 90 days. On the WOMAC index, significant reduction (p < 0.05) was observed on the domains of pain and stiffness. A significant reduction was observed on CRP levels. AQUA-TURM® did not produce any significant adverse effects on clinical and laboratory parameters and was well tolerated. Conclusion: Supplementation of AQUATURM® in individuals suffering from Osteoarthritis of Knee joint showed significant reduction in pain and swelling showing its analgesic and anti-inflammatory effect.

Publisher

Research Square Platform LLC

Reference22 articles.

1. Hangerman D.; N. Engl. J. Med: 320:1322.1989.

2. Guidelines for the medical management of osteoarthritis. Part I.;Hochberg MC;Arthritis Rheum. 1995

3. New molecular targets for the treatment of osteoarthritis;Maria Jose Alcaraz;Biochemical Pharmacology,2010

4. Felson DT, Laurence RC, Diepee Pa et al; Ann. Intern. Med; 133(9); 726–737; 2000

5. Randomized double blind study to document Efficacy and Safety of Refecoxib + Betacyclodextrin complex in comparison with Rofecoxib in Patients suffering from Osteoarthritis;Chopra A;Ind. Med.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3